Dataset Information

YBEY is an essential biogenesis factor for mitochondrial ribosomes

ABSTRACT: Ribosome biogenesis is a key cellular process involving numerous protein factors, some of which are deeply conserved. This is namely the case of the bacterial endoribonuclease YbeY, whose loss is associated with ribosomal abnormalities, profound changes in gene expression, altered metabolism and death. Surprisingly, YbeY is also widespread among eukaryotes. Here we provide an in-depth characterisation of the human YBEY homologue localising in mitochondria. We show that YBEY loss results in a severe mitochondrial phenotype and complete inability of mitochondria to translate proteins and, consequently, perform oxidative phosphorylation. Through interactions with the important disease protein p32 and other factors, YBEY functions to recruit the mitoribosomal protein uS11m to the nascent small subunit in order to complete the assembly of initiation-competent ribosomal particles. This likely conserved mechanism shows striking similarities with final stages of the cytosolic ribosome biogenesis and may provide an important late checkpoint before the mitoribosome engages in translation.

INSTRUMENT(S): TripleTOF 5600, Q Exactive

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Lauriane Kuhn

LAB HEAD: Alexander Smirnov

PROVIDER: PXD014959 | Pride | 2021-04-29

REPOSITORIES: Pride

ACCESS DATA

Similar Datasets

Project description:Fibro-adipogenic progenitors (FAPs) are emerging cellular components of the skeletal muscle regenerative environment. The alternative functional phenotype of FAPs - either supportive of muscle regeneration or promoting fibro-adipogenic degeneration M-bM-^@M-^S is a key determinant in the pathogenesis of muscular diseases, including Duchenne Muscular Dystrophy (DMD). However, the molecular regulation of FAPs is still unknown. We show here that an M-bM-^@M-^\HDAC-myomiR-BAF60 variant networkM-bM-^@M-^] regulates the functional phenotype of FAPs in dystrophic muscles of mdx mice. Combinatorial analysis of gene expression microarray and genome-wide chromatin remodeling by Nuclease accessibility (NA)-seq revealed that HDAC inhibitors de-repress a M-bM-^@M-^\latentM-bM-^@M-^] myogenic program in FAPs from dystrophic muscles at early stages of disease progression. In these cells HDAC inhibition promoted the expression of two core components of the myogenic transcriptional machinery, MyoD and BAF60C, and upregulated the myomiRs (miRs) 1.2, 133 and 206, which target two alternative BAF60 variants (BAF60A and B) ultimately leading to the activation of a pro-myogenic program at the expense of the fibro-adipogenic phenotype. By contrast, FAPs from dystrophic muscles at late stages of disease progression displayed resistance to HDACi-induced chromatin remodeling at myogenic loci and fail to activate the pro-myogenic phenotype. These results reveal a previously unappreciated disease stage-specific bipotency of mesenchimal cells within the regenerative environment of dystrophic muscles. Resolution of such bi-potency by epigenetic interventions, such as HDACi, provides the molecular rationale for the in situ reprogramming of target cells to promote therapeutic regeneration of dystrophic muscles. Genome-wide chromatin accessibility patterns in FAPs cells derived from mdx mice at different ages treated either with HDAC inhibitor Trichostatin A (TSA) or with vehicle (saline solution) were assessed using NA-seq (PMID: 19289091)

Dataset Information

YBEY is an essential biogenesis factor for mitochondrial ribosomes

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure